Cargando…

Hypnotic drug risks of mortality, infection, depression, and cancer: but lack of benefit

This is a review of hypnotic drug risks and benefits. Almost every month, new information appears about the risks of hypnotics (sleeping pills). The most important risks of hypnotics include excess mortality (especially overdose deaths, quiet deaths at night, and suicides), infections, cancer, depre...

Descripción completa

Detalles Bibliográficos
Autor principal: Kripke, Daniel F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: F1000 Research Limited 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4890308/
https://www.ncbi.nlm.nih.gov/pubmed/27303633
http://dx.doi.org/10.12688/f1000research.8729.3
_version_ 1782435099638235136
author Kripke, Daniel F.
author_facet Kripke, Daniel F.
author_sort Kripke, Daniel F.
collection PubMed
description This is a review of hypnotic drug risks and benefits. Almost every month, new information appears about the risks of hypnotics (sleeping pills). The most important risks of hypnotics include excess mortality (especially overdose deaths, quiet deaths at night, and suicides), infections, cancer, depression, automobile crashes, falls, other accidents, and hypnotic-withdrawal insomnia. Short-term use of one-two prescriptions is associated with even greater risk per dose than long-term use. Hypnotics have usually been prescribed without approved indication, most often with specific contraindications, but even when indicated, there is little or no benefit. The recommended doses objectively increase sleep little if at all, daytime performance is often made worse (not better) and the lack of general health benefits is commonly misrepresented in advertising. Treatments such as the cognitive behavioral treatment of insomnia and bright light treatment of circadian rhythm disorders offer safer and more effective alternative approaches to insomnia.
format Online
Article
Text
id pubmed-4890308
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher F1000 Research Limited
record_format MEDLINE/PubMed
spelling pubmed-48903082016-06-13 Hypnotic drug risks of mortality, infection, depression, and cancer: but lack of benefit Kripke, Daniel F. F1000Res Review This is a review of hypnotic drug risks and benefits. Almost every month, new information appears about the risks of hypnotics (sleeping pills). The most important risks of hypnotics include excess mortality (especially overdose deaths, quiet deaths at night, and suicides), infections, cancer, depression, automobile crashes, falls, other accidents, and hypnotic-withdrawal insomnia. Short-term use of one-two prescriptions is associated with even greater risk per dose than long-term use. Hypnotics have usually been prescribed without approved indication, most often with specific contraindications, but even when indicated, there is little or no benefit. The recommended doses objectively increase sleep little if at all, daytime performance is often made worse (not better) and the lack of general health benefits is commonly misrepresented in advertising. Treatments such as the cognitive behavioral treatment of insomnia and bright light treatment of circadian rhythm disorders offer safer and more effective alternative approaches to insomnia. F1000 Research Limited 2018-11-12 /pmc/articles/PMC4890308/ /pubmed/27303633 http://dx.doi.org/10.12688/f1000research.8729.3 Text en Copyright: © 2018 Kripke DF http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review
Kripke, Daniel F.
Hypnotic drug risks of mortality, infection, depression, and cancer: but lack of benefit
title Hypnotic drug risks of mortality, infection, depression, and cancer: but lack of benefit
title_full Hypnotic drug risks of mortality, infection, depression, and cancer: but lack of benefit
title_fullStr Hypnotic drug risks of mortality, infection, depression, and cancer: but lack of benefit
title_full_unstemmed Hypnotic drug risks of mortality, infection, depression, and cancer: but lack of benefit
title_short Hypnotic drug risks of mortality, infection, depression, and cancer: but lack of benefit
title_sort hypnotic drug risks of mortality, infection, depression, and cancer: but lack of benefit
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4890308/
https://www.ncbi.nlm.nih.gov/pubmed/27303633
http://dx.doi.org/10.12688/f1000research.8729.3
work_keys_str_mv AT kripkedanielf hypnoticdrugrisksofmortalityinfectiondepressionandcancerbutlackofbenefit